Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Essex Property Trust reports strong Q3 earnings, but its stock declines amid mixed market performance.
Red Sox sign veteran catcher Jason Delay to minor-league deal, adding depth as Carlos Narvaez and Connor Wong recover from surgeries.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Essex Property Trust reports strong Q3 earnings, but its stock declines amid mixed market performance.
Red Sox sign veteran catcher Jason Delay to minor-league deal, adding depth as Carlos Narvaez and Connor Wong recover from surgeries.